ATE215938T1 - Serin-protease-inhibitoren: derivate des isothiazolidin-3-on-1,1-dioxids und des 3-oxo-1,2,5-thiadiazolidin-1,1-dioxids - Google Patents
Serin-protease-inhibitoren: derivate des isothiazolidin-3-on-1,1-dioxids und des 3-oxo-1,2,5-thiadiazolidin-1,1-dioxidsInfo
- Publication number
- ATE215938T1 ATE215938T1 AT95908003T AT95908003T ATE215938T1 AT E215938 T1 ATE215938 T1 AT E215938T1 AT 95908003 T AT95908003 T AT 95908003T AT 95908003 T AT95908003 T AT 95908003T AT E215938 T1 ATE215938 T1 AT E215938T1
- Authority
- AT
- Austria
- Prior art keywords
- dioxide
- thiadiazolidine
- oxo
- derivatives
- isothiazolidine
- Prior art date
Links
- ASJJYLPJOJGZAW-UHFFFAOYSA-N 1,1-dioxo-1,2-thiazolidin-3-one Chemical class O=C1CCS(=O)(=O)N1 ASJJYLPJOJGZAW-UHFFFAOYSA-N 0.000 title abstract 2
- JSZAZZQHDRHICK-UHFFFAOYSA-N 1,1-dioxo-1,2,5-thiadiazolidin-3-one Chemical compound O=C1CNS(=O)(=O)N1 JSZAZZQHDRHICK-UHFFFAOYSA-N 0.000 title 1
- 239000003001 serine protease inhibitor Substances 0.000 title 1
- XOAKQCOPHMCADA-UHFFFAOYSA-N 4,8-dioxatricyclo[5.1.0.03,5]octane Chemical compound C1C2OC2CC2OC12 XOAKQCOPHMCADA-UHFFFAOYSA-N 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000002257 antimetastatic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/177,352 US5550139A (en) | 1994-01-03 | 1994-01-03 | Serine protease inhibitors |
| PCT/US1995/000236 WO1995018797A1 (en) | 1994-01-03 | 1995-01-03 | Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE215938T1 true ATE215938T1 (de) | 2002-04-15 |
Family
ID=22648272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95908003T ATE215938T1 (de) | 1994-01-03 | 1995-01-03 | Serin-protease-inhibitoren: derivate des isothiazolidin-3-on-1,1-dioxids und des 3-oxo-1,2,5-thiadiazolidin-1,1-dioxids |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5550139A (de) |
| EP (1) | EP0739338B1 (de) |
| JP (1) | JPH09509922A (de) |
| AT (1) | ATE215938T1 (de) |
| AU (1) | AU686316B2 (de) |
| CA (1) | CA2179913A1 (de) |
| DE (1) | DE69526330D1 (de) |
| NZ (2) | NZ279392A (de) |
| WO (1) | WO1995018797A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001813A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Val-pro containing α-keto oxadiazoles as serine protease inhibitors |
| US6159938A (en) * | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
| US6001811A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Serine protease inhibitors--N-substituted derivatives |
| US5998379A (en) * | 1994-11-21 | 1999-12-07 | Cortech Inc. | Serine protease inhibitors-proline analogs |
| US6100238A (en) * | 1994-11-21 | 2000-08-08 | Cortech Inc. | Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors |
| US6015791A (en) * | 1994-11-21 | 2000-01-18 | Cortech Inc. | Serine protease inhibitors-cycloheptane derivatives |
| US6001814A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Serine protease inhibitors |
| US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| US20020119985A1 (en) | 1994-11-21 | 2002-08-29 | Albert Gyorkos | Serine protease inhibitors |
| US6150334A (en) * | 1994-11-21 | 2000-11-21 | Cortech, Inc. | Serine protease inhibitors-tripeptoid analogs |
| US5750546A (en) * | 1994-12-02 | 1998-05-12 | Sanofi Winthrop, Inc. | 2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof |
| US5556909A (en) * | 1994-12-02 | 1996-09-17 | Sanofi Winthrop Inc. | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof |
| US5494925A (en) * | 1994-12-02 | 1996-02-27 | Sterling Winthrop Inc. | 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| US5693515A (en) * | 1995-04-28 | 1997-12-02 | Arris Pharmaceutical Corporation | Metal complexed serine protease inhibitors |
| US6420401B1 (en) * | 1997-08-22 | 2002-07-16 | Wichita State University | 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives |
| US6656910B2 (en) | 1997-12-04 | 2003-12-02 | Cortech, Inc. | Serine protease inhibitors |
| US20030190368A1 (en) * | 1998-03-11 | 2003-10-09 | Roland Stoughton | Methods of diagnosis and triage using cell activation measures |
| EP1089752A4 (de) | 1998-06-03 | 2002-01-02 | Cortech Inc | Alpha-keto oxadiazole als serinprotease inhibitoren |
| DE19856071A1 (de) * | 1998-12-04 | 2000-06-15 | Degussa | Verfahren zur Vermeidung einer Gewässerkontamination mit ortsfremden Organismen |
| US6495358B1 (en) | 2000-04-19 | 2002-12-17 | Wichita State University | Sulfamide and bis-sulfamide amino acid derivatives as inhibitors of proteolytic enzymes |
| IT1320393B1 (it) * | 2000-06-05 | 2003-11-26 | Cselt Centro Studi Lab Telecom | Procedimento per il modellamento elettromagnetico di componenti esistemi elettronici. |
| DE10155075A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Cyclische Sulfonamide |
| PL373763A1 (en) * | 2002-04-30 | 2005-09-19 | Ucb, S.A. | 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| CN1720240B (zh) * | 2002-10-09 | 2010-10-27 | 先灵公司 | 作为cxc-和cc-趋化因子受体配体的噻二唑二氧化物和噻二唑氧化物 |
| AU2003300447B2 (en) * | 2002-12-30 | 2009-09-03 | Vertex Pharmaceuticals Incorporated | Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| JP4939229B2 (ja) * | 2003-12-19 | 2012-05-23 | シェーリング コーポレイション | Ｃｘｃ−ケモカインレセプターリガンドおよびｃｃ−ケモカインレセプターリガンドとしてのチアジアゾール |
| WO2005068460A1 (en) * | 2003-12-22 | 2005-07-28 | Schering Corporation | Isothiazole dioxides as cxc- and cc- chemokine receptor ligands |
| US20060045883A1 (en) * | 2004-08-26 | 2006-03-02 | Jeffrey Molldrem | Anti-cancer vaccines |
| GB0507577D0 (en) * | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| CA2613428A1 (en) * | 2005-06-29 | 2007-01-11 | Schering Corporation | 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| CN101253165A (zh) * | 2005-06-29 | 2008-08-27 | 先灵公司 | 作为cxc－化学活素受体配体的二取代的二唑 |
| IL169622A0 (en) * | 2005-07-11 | 2007-07-04 | Yeda Res & Dev | Methods of screening modulators of interleukin-32 (il-32)modulators of il-32 identified by said methods and their use |
| EP3971178A1 (de) | 2012-03-07 | 2022-03-23 | The McLean Hospital Corporation | Aminochinolinderivate und verwendungen davon |
| CN104387378B (zh) * | 2014-11-24 | 2017-08-25 | 沈阳药科大学 | 4‑噻唑烷酮类衍生物及其应用 |
| GB201617935D0 (en) | 2016-10-24 | 2016-12-07 | Queens University Of Belfast The | Binding compound and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0124067B1 (de) * | 1983-05-04 | 1986-12-17 | CASSELLA Aktiengesellschaft | 2-(Aminoalkyl)-pyrrol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5306818A (en) * | 1990-11-01 | 1994-04-26 | Sterling Winthrop Inc. | Tetrahydro 2-saccharinylmerthyl aryl carboxylates |
-
1994
- 1994-01-03 US US08/177,352 patent/US5550139A/en not_active Expired - Lifetime
-
1995
- 1995-01-03 JP JP7518638A patent/JPH09509922A/ja not_active Ceased
- 1995-01-03 NZ NZ279392A patent/NZ279392A/en not_active IP Right Cessation
- 1995-01-03 DE DE69526330T patent/DE69526330D1/de not_active Expired - Lifetime
- 1995-01-03 AT AT95908003T patent/ATE215938T1/de not_active IP Right Cessation
- 1995-01-03 CA CA002179913A patent/CA2179913A1/en not_active Abandoned
- 1995-01-03 AU AU15998/95A patent/AU686316B2/en not_active Ceased
- 1995-01-03 WO PCT/US1995/000236 patent/WO1995018797A1/en not_active Ceased
- 1995-01-03 EP EP95908003A patent/EP0739338B1/de not_active Expired - Lifetime
-
1998
- 1998-02-16 NZ NZ329766A patent/NZ329766A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1599895A (en) | 1995-08-01 |
| JPH09509922A (ja) | 1997-10-07 |
| EP0739338B1 (de) | 2002-04-10 |
| WO1995018797A1 (en) | 1995-07-13 |
| DE69526330D1 (de) | 2002-05-16 |
| US5550139A (en) | 1996-08-27 |
| NZ279392A (en) | 1998-05-27 |
| AU686316B2 (en) | 1998-02-05 |
| NZ329766A (en) | 2001-02-23 |
| EP0739338A1 (de) | 1996-10-30 |
| CA2179913A1 (en) | 1995-07-13 |
| EP0739338A4 (de) | 1997-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69526330D1 (de) | Serin-protease-inhibitoren: derivate des isothiazolidin-3-on-1,1-dioxids und des 3-oxo-1,2,5-thiadiazolidin-1,1-dioxids | |
| ATE382041T1 (de) | Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen | |
| ATE199545T1 (de) | Inhibitoren retroviraler proteasen | |
| ATE427300T1 (de) | Heterocyclisch substituierte amide als calpainhemmer | |
| DE122008000021I2 (de) | Sulfonamidderivate als Wirkstoff-Vorläufer vom Inhibitoren der Aspartyl-Protease | |
| NO941937D0 (no) | Sakarinderivater som inhiberer proteolytiske enzymer | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| MY136141A (en) | Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors | |
| NO950297D0 (no) | Prolinamidderivater | |
| DE60124684D1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
| ATE233552T1 (de) | Thiol-sulfonen als metalloproteinaseinhibitoren | |
| ATE193304T1 (de) | Inhibitoren der menschlichen neutrophilenelastase | |
| TR200000059T2 (tr) | Piridin türevleri | |
| ATE196761T1 (de) | Inhibitoren retroviraler proteasen | |
| ATE355284T1 (de) | Inhibitoren von serinproteasen | |
| DE69819349D1 (de) | 1-amino-7-isochinolin-derivate als serin protease inhibitoren | |
| DK0599444T3 (da) | Dobbeltvirkende inhibitorer | |
| DE69232929D1 (de) | Saccharinderivate als proteolytische Enzyminhibitoren | |
| BG105112A (bg) | Средство с антидепресивно действие | |
| ATE170868T1 (de) | Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen | |
| TR200002542T2 (tr) | Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri | |
| BG104885A (en) | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect | |
| TR200000272T2 (tr) | Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri. | |
| ATE335485T1 (de) | Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease | |
| WO2000037464A3 (en) | 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |